Suchergebnisse - "Carbone, Salvatore"

PubPharm (11)

1

Cardiac remodeling with SGLT2 inhibitors in heart failure with reduced ejection fraction

enthalten in: Minerva cardiology and angiology | 2024

von Romeo, F. | Del Buono, M. | Aguilar-Gallardo, J. | +7

2

SGLT2 inhibitors in Patients Admitted for Acute Heart Failure : The Earlier the Better

enthalten in: The American journal of cardiology | 2024

von Carbone, S. | Abbate, A.

3

The sodium-glucose co-transporter 2 inhibitor dapagliflozin improves prognosis in systolic heart failure independent of the obesity paradox

enthalten in: European journal of heart failure | 2021

von Carbone, S. | daSilva-deAbreu, A. | Lavie, C.

CommentOn: Eur J Heart Fail. 2021 Oct;23(10):1662-1672. - PMID 34272791

4

Effect of Canagliflozin Compared With Sitagliptin on Serum Lipids in Patients with Type 2 Diabetes Mellitus and Heart Failure with Reduced Ejection Fraction : A Post-Hoc Analysis of the CANA-HF Study

enthalten in: Journal of cardiovascular pharmacology | 2021

von Dixon, D. | Billingsley, H. | Canada, J. | +7

5

The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction : The CANA-HF study

enthalten in: Diabetes/metabolism research and reviews | 2020

von Carbone, S. | Billingsley, H. | Canada, J. | +20

6

SGLT2 Inhibition, Visceral Adiposity, Weight, and Type 2 Diabetes Mellitus

enthalten in: Obesity (Silver Spring, Md.) | 2020

von Carbone, S. | O'Keefe, J. | Lavie, C.

7

The CANVAS Program : implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus

enthalten in: Cardiovascular diabetology | 2019

von Carbone, S. | Dixon, D.

8

Novel and Emerging Therapeutics for Primary Prevention of Cardiovascular Disease

enthalten in: The American journal of medicine | 2019

von Buckley, L. | Carbone, S. | Aldemerdash, A. | +2

9

Effects of empagliflozin on cardiorespiratory fitness and significant interaction of loop diuretics

enthalten in: Diabetes, obesity & metabolism | 2018

von Carbone, S. | Canada, J. | Billingsley, H. | +11

10

Treatment of Hypertension to Prevent and Treat Heart Failure in Diabetic Patients Should Include Sodium Glucose Co-Transporter 2 Inhibitors

enthalten in: JACC. Heart failure | 2018

von Carbone, S. | Dixon, D. | Abbate, A.

CommentOn: JACC Heart Fail. 2017 Aug;5(8):543-551. - PMID 28711447